SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-21-016871
Filing Date
2021-07-13
Accepted
2021-07-13 17:49:03
Documents
1
Period of Report
2021-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1356
  Complete submission text file 0001437749-21-016871.txt   2864
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address C/O THE CHEESECAKE FACTORY INC 26901 MALIBU HILLS ROAD CALABASAS HILLS CA 91301
Business Address
CAPPELLO ALEXANDER L (Reporting) CIK: 0001193532 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35076 | Film No.: 211088808